305 related articles for article (PubMed ID: 15743427)
21. [Establishing an experimental guinea pig model of dermatophytosis Using Trichophyton rubrum].
Chen XJ; Shen YN; Lü GX; Liu WD
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Oct; 30(5):599-602. PubMed ID: 19024394
[TBL] [Abstract][Full Text] [Related]
22. In vivo activity of sertaconazole in experimental dermatophytosis in guinea pigs.
Palacín C; Sacristán A; Ortiz JA
Arzneimittelforschung; 1992 May; 42(5A):714-8. PubMed ID: 1627189
[TBL] [Abstract][Full Text] [Related]
23. In vivo activity and metabolic fate of 2-(2,3,3-triiodoallyl)tetrazole (ME1401), a novel antifungal agent.
Fukuyasu H; Orikasa Y; Kai F; Inouye S; Kitasato I; Yamaguchi H
Drugs Exp Clin Res; 1989; 15(8):335-47. PubMed ID: 2598775
[TBL] [Abstract][Full Text] [Related]
24. Antifungal activities of Astragalus verus Olivier. against Trichophyton verrucosum on in vitro and in vivo guinea pig model of dermatophytosis.
Mikaeili A; Modaresi M; Karimi I; Ghavimi H; Fathi M; Jalilian N
Mycoses; 2012 Jul; 55(4):318-25. PubMed ID: 21838718
[TBL] [Abstract][Full Text] [Related]
25. Assessment of in vivo activity of bifonazole against dermatophytic infection in guinea pigs on the basis of the amount of a specific fungal cell wall component chitin in the infected skin.
Uchida K; Yamaguchi H
Dermatologica; 1984; 169 Suppl 1():47-9. PubMed ID: 6526091
[TBL] [Abstract][Full Text] [Related]
26. In vivo antifungal activity of dipyrithione against Trichophyton rubrum on guinea pig dermatophytosis models.
Song X; Wei YX; Lai KM; He ZD; Zhang HJ
Biomed Pharmacother; 2018 Dec; 108():558-564. PubMed ID: 30243089
[TBL] [Abstract][Full Text] [Related]
27. Experimental guinea pig model of dermatophytosis: a simple and useful tool for the evaluation of new diagnostics and antifungals.
Saunte DM; Hasselby JP; Brillowska-Dabrowska A; Frimodt-Møller N; Svejgaard EL; Linnemann D; Nielsen SS; Haedersdal M; Arendrup MC
Med Mycol; 2008 Jun; 46(4):303-13. PubMed ID: 18415837
[TBL] [Abstract][Full Text] [Related]
28. [Evaluation the antimycotic activity of itraconazole in human stratum corneum with vitro fungi cultivation].
Xu W; Zhao JY; Wang L
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(8):530-3. PubMed ID: 15949332
[TBL] [Abstract][Full Text] [Related]
29. Antifungal activity of the new agent latoconazole in two tinea models.
Ohmi T; Konaka S; Uchida M; Yamaguchi H
Arzneimittelforschung; 1991 Aug; 41(8):847-51. PubMed ID: 1781809
[TBL] [Abstract][Full Text] [Related]
30. [A study on effectiveness of treatment and prevention of relapse using topical administration of terbinafine in a guinea pig model for tinea pedis].
Uchida K; Kudoh M; Yamaguchi H
Jpn J Antibiot; 1994 Oct; 47(10):1407-12. PubMed ID: 7807700
[TBL] [Abstract][Full Text] [Related]
31. A case of bullous tinea pedis with dermatophytid reaction caused by Trichophyton violaceum.
Romano C; Rubegni P; Ghilardi A; Fimiani M
Mycoses; 2006 May; 49(3):249-50. PubMed ID: 16681820
[TBL] [Abstract][Full Text] [Related]
32. Antifungal activity of chitooligosaccharides against the dermatophyte Trichophyton rubrum.
Mei YX; Dai XY; Yang W; Xu XW; Liang YX
Int J Biol Macromol; 2015; 77():330-5. PubMed ID: 25841377
[TBL] [Abstract][Full Text] [Related]
33. [Experimental studies on the effect of antimycotic substances in spray form (Afungin-spray)].
Schönborn C; Bremer D; Giessner R
Dermatol Monatsschr; 1969; 155(11):857-68. PubMed ID: 5378709
[No Abstract] [Full Text] [Related]
34. Antifungal activity of aminopyrrolnitrin against Trichophyton verrucosum in a guinea pig model of dermatophytosis.
Lee HG; Bok EY; Jung YH; Hur TY; Kim YO; Kong HJ; Kim DG; Kim YS; Oem JK
Mycoses; 2024 May; 67(5):e13748. PubMed ID: 38783563
[TBL] [Abstract][Full Text] [Related]
35. Antimicrobial and antifungal activities of a novel cationic antimicrobial peptide, omiganan, in experimental skin colonisation models.
Rubinchik E; Dugourd D; Algara T; Pasetka C; Friedland HD
Int J Antimicrob Agents; 2009 Nov; 34(5):457-61. PubMed ID: 19524411
[TBL] [Abstract][Full Text] [Related]
36. Effectiveness and tolerability of a standardized extract from Ageratina pichinchensis on patients with tinea pedis: an explorative pilot study controlled with ketoconazole.
Romero-Cerecero O; Rojas G; Navarro V; Herrera-Arellano A; Zamilpa-Alvarez A; Tortoriello J
Planta Med; 2006 Nov; 72(14):1257-61. PubMed ID: 17051456
[TBL] [Abstract][Full Text] [Related]
37. In vivo efficacy and pharmacokinetics of voriconazole in an animal model of dermatophytosis.
Saunte DM; Simmel F; Frimodt-Moller N; Stolle LB; Svejgaard EL; Haedersdal M; Kloft C; Arendrup MC
Antimicrob Agents Chemother; 2007 Sep; 51(9):3317-21. PubMed ID: 17576826
[TBL] [Abstract][Full Text] [Related]
38. Morphological evidences for onion-induced growth inhibition of Trichophyton rubrum and Trichophyton mentagrophytes.
Ghahfarokhi MS; Goodarzi M; Abyaneh MR; Al-Tiraihi T; Seyedipour G
Fitoterapia; 2004 Dec; 75(7-8):645-55. PubMed ID: 15567239
[TBL] [Abstract][Full Text] [Related]
39. Species distribution and antifungal susceptibilities of dermatophytes during a one year period at a university hospital in Turkey.
Ozkutuk A; Ergon C; Yulug N
Mycoses; 2007 Mar; 50(2):125-9. PubMed ID: 17305776
[TBL] [Abstract][Full Text] [Related]
40. In-vitro and in-vivo anti-Trichophyton activity of essential oils by vapour contact.
Inouye S; Uchida K; Yamaguchi H
Mycoses; 2001 May; 44(3-4):99-107. PubMed ID: 11413931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
